Effects of edaravone combined with batroxobin in treatment of cerebral infarction patients
Guan Ying
Abstract
Guan Ying
Abstract
Objective To evaluate the character and effect of edaravone combined with batroxobin in treatment of cerebral infarction. Methods 120 patients suffered with cerebral infarction were divided into combined group(edaravone with batroxobin),batroxobin group,edaravone group and control group.Each group had 30 patients.Changes of neural function and FIB content were studied.Results The ESS grade of combined group was significantly higher than that of control group after treatment(P(0.05)).On 21d and 90d after treatment it was significantly higher than those of edaravone and batroxobin group(P(0.05)).The significant effect rate of combined group were significantly higher than which of other groups on 90d(P(0.05)).The efficient rate of combined group was significantly higher than those of other groups after 21 days of treatment(P(0.05)).Contends of FIB in combined group and batroxobin group were significantly decreased after treatment(P(0.01)).Conclusion Edaravone combined with Batroxobin can notably and safely improve the symptom of cerebral infarction patients.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the character and effect of edaravone combined with batroxobin in treatment of cerebral infarction. Methods 120 patients suffered with cerebral infarction were divided into combined group(edaravone with batroxobin),batroxobin group,edaravone group and control group.Each group had 30 patients.Changes of neural function and FIB content were studied.Results The ESS grade of combined group was significantly higher than that of control group after treatment(P(0.05)).On 21d and 90d after treatment it was significantly higher than those of edaravone and batroxobin group(P(0.05)).The significant effect rate of combined group were significantly higher than which of other groups on 90d(P(0.05)).The efficient rate of combined group was significantly higher than those of other groups after 21 days of treatment(P(0.05)).Contends of FIB in combined group and batroxobin group were significantly decreased after treatment(P(0.01)).Conclusion Edaravone combined with Batroxobin can notably and safely improve the symptom of cerebral infarction patients.
Key concepts: Batroxobin, Edaravone, Medicine, Cerebral infarction, Anesthesia, Internal medicine, Gastroenterology, Ischemia